A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons

scientific article

A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FGENE.2014.00202
P932PMC publication ID4082091
P698PubMed publication ID25071831
P5875ResearchGate publication ID264393877

P2093author name stringChristopher D Link
Susan Wang
Shin Murakami
Hana Murakami
Kevin Machino
P2860cites workAmyloid beta: multiple mechanisms of toxicity and only some protective effects?Q27008826
Keeping track of worm trackersQ27012579
Alzheimer's disease: genes, proteins, and therapyQ28131806
Maintenance of C. elegansQ29617844
Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory lossQ30420041
High-throughput behavioral analysis in C. elegansQ30501986
Thermotaxis is a robust mechanism for thermoregulation in Caenorhabditis elegans nematodesQ30566713
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegansQ33902367
Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic viewQ34268430
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsQ34418781
Drosophila melanogaster as a model organism for Alzheimer's diseaseQ34464181
β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neuronsQ35872520
Neurologic and motor dysfunctions in APP transgenic miceQ36347389
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's diseaseQ36460071
Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's diseaseQ36949391
Alzheimer disease in the United States (2010-2050) estimated using the 2010 censusQ37035610
Biomarker modeling of Alzheimer's diseaseQ37592824
Pathways linking Abeta and tau pathologies.Q37775659
The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysisQ37953181
Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer diseaseQ38078146
Frailty among Alzheimer's disease patientsQ38097898
Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicityQ38139529
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?Q38912261
Thermotaxis in Caenorhabditis elegans analyzed by measuring responses to defined Thermal stimuli.Q43030766
Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-betaQ43181445
Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's diseaseQ46318965
Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of AmyloidosisQ46569493
Aging-dependent and -independent modulation of associative learning behavior by insulin/insulin-like growth factor-1 signal in Caenorhabditis elegans.Q48942620
Association between frailty and dementia: a population-based study.Q50694550
Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans.Q51992813
P921main subjectCaenorhabditis elegansQ91703
overexpressionQ61643320
P304page(s)202
P577publication date2014-07-04
P1433published inFrontiers in GeneticsQ2499875
P1476titleA semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons
P478volume5

Reverse relations

cites work (P2860)
Q34010229Alzheimer's patient feedback to complement research using model systems for cognitive aging and dementia
Q58775193D-Track-A semi-automatic 3D video-tracking technique to analyse movements and routines of aquatic animals with application to captive dolphins
Q59808737Frailty and as a Benchtop Animal Model for Screening Drugs Including Natural Herbs
Q41497184In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model.
Q51533022Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.

Search more.